Media Releases

Date Title Download
Date15.12.2015 TitleSwissmedic approves Akynzeo® (netupitant/palonosetron) for use in the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Switzerland Download Swissmedic approves Akynzeo® (netupitant/palonosetron) for use in the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Switzerland
Date01.12.2015 TitleDivision of the Galenica Group planned for the 4th quarter of 2016 Download Division of the Galenica Group planned for the 4th quarter of 2016
Date22.10.2015 TitleSFI acquires Potters and the Equazen™ brand portfolio from Vifor Pharma Download SFI acquires Potters and the Equazen™ brand portfolio from Vifor Pharma
Date30.09.2015 TitleKissei receives Japanese approval for P-TOL® (in the USA and Europe commercialized as Velphoro®) Download Kissei receives Japanese approval for P-TOL® (in the USA and Europe commercialized as Velphoro®)
Date31.08.2015 TitleMeta-analysis links Ferinject® treatment of iron deficiency to reduced rate for cardiovascular hospitalisations and deaths in systolic heart failure patients Download Meta-analysis links Ferinject® treatment of iron deficiency to reduced rate for cardiovascular hospitalisations and deaths in systolic heart failure patients
Date11.08.2015 TitleGalenica Group half-year results 2015 Download Galenica Group half-year results 2015
Date11.08.2015 TitleVifor Fresenius Medical Care Renal Pharma enters into partnership with Relypsa to commercialise Patiromer FOS Download Vifor Fresenius Medical Care Renal Pharma enters into partnership with Relypsa to commercialise Patiromer FOS
Date11.08.2015 TitleVifor Fresenius Medical Care Renal Pharma and Relypsa Enter into Partnership to Commercialize Patiromer Fos in Europe and Additional Territories Download Vifor Fresenius Medical Care Renal Pharma and Relypsa Enter into Partnership to Commercialize Patiromer Fos in Europe and Additional Territories
Date03.07.2015 TitleGalenica Santé: new strategic priorities and changes to the organisational structure Download Galenica Santé: new strategic priorities and changes to the organisational structure
Date28.05.2015 TitleGalenica and Roche enter into exclusive license agreement for the commercialisation of Mircera® in the US Download Galenica and Roche enter into exclusive license agreement for the commercialisation of Mircera® in the US
Date28.05.2015 TitleVifor Fresenius Medical Care Renal Pharma to expand its business activities Download Vifor Fresenius Medical Care Renal Pharma to expand its business activities
Date07.05.2015 Title2015 Annual General Meeting of Galenica Ltd. Download 2015 Annual General Meeting of Galenica Ltd.
Date13.04.2015 TitleMeasures to ensure strategy implementation Download Measures to ensure strategy implementation
Date10.03.2015 TitleResults of the Galenica Group for 2014 Download Results of the Galenica Group for 2014
Date27.01.2015 TitleVelphoro® receives Swissmedic approval Download Velphoro® receives Swissmedic approval
Date21.01.2015 TitleGalenica Group sales 2014 Download Galenica Group sales 2014